aDivision of Tuberculosis and Bacterial Respiratory Infections, Korea National Institute of Health, Korea Centers for Disease Control and Prevention, Osong, Korea
bDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea
cDepartment of Microbiology and Immunology, College of Medicine, Seoul National University, Seoul, Korea
dCancer Research Institute, College of Medicine, Seoul National University, Seoul, Korea
eLiver Research Institute, College of Medicine, Seoul National University, Seoul, Korea
© 2014 Published by Elsevier B.V. on behalf of Korea Centers for Disease Control and Prevention.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Gene | Primer | Sequences (5′–3′) | Amplicon size (bp) | No. of alleles |
---|---|---|---|---|
argH | argH-F | AGTCGTGCAGGGTGACGTAG | 495 | 11 |
argH-R | CCACCCTGTTCCGGATGT | |||
cya | cya-F | CCGTGCGGATCCTTCAGT | 660 | 7 |
cya-R | GTGCTGTTGCTGGGCATC | |||
glpK | glpK-F | ATCGGATCGCCAGTAGGG | 670 | 6 |
glpK-R | GACACCTGGGTGTTGTGGAA | |||
gnd | gnd-F | TGGCGGTCACCACGACAC | 555 | 4 |
gnd-R | GATCACGGCGCAGGTCTT | |||
murC | murC-F | GTTGCTCGGGGTCCAGGT | 607 | 4 |
murC-R | GTCGTCGCTGGACCTGTTG | |||
pta | pta-F | GGTTCGATGCCGAATTGTG | 665 | 8 |
pta-R | CACGTCGACATCACCGATCT |
Set | Alias | PCR primer pairs (5′–3′, labeling indicated) | Primer concentration |
---|---|---|---|
Set 1 | MIN18 | GCCGAACCATTTGGCGAAC(VIC) | 4μM |
GGATTCGGCCGCGCAATTC | |||
MIN19 | CATGGTTCGCCCTCTACAC(PET) | 5μM | |
TAGGGGCAGGTCATCGAAG | |||
MIN20 | GCTGAGCTACAGCCTCGAC(NED) | 7.5μM | |
CGACGCCGATGACGTAAAC | |||
Set 2 | MIN22 | TCAGGAATGGGTCCGGTTC(FAM) | 5μM |
AGCTCGTGACGACGGAAAC | |||
MIN31 | CGACCGCATCCAGAAACAG(VIC) | 5μM | |
GCTCTATGACGACCTCAAG | |||
MIN33 | GTGCAGTTCAACCACGAAC(PET) | 7.5μM | |
GGCGTTGAACACGTTGGTG |
Antibiotic susceptibility type | Antibacterial drug | AS Type No. (%) | |||||||
---|---|---|---|---|---|---|---|---|---|
CLA | MXF | RIF | SXT | AMI | LZD | CIP | DOX | ||
AST1 | S | R | R | R | S | R | R | R | 28 (63.6) |
AST2 | S | R | R | S | S | R | R | R | 7 (15.9) |
AST3 | S | R | R | R | R | R | R | R | 4 (9.1) |
AST4 | S | S | S | R | S | S | S | S | 2 (4.5) |
AST5 | S | R | R | S | R | R | R | R | 1 (2.3) |
AST6 | S | S | S | S | S | S | S | S | 1 (2.3) |
AST7 | S | S | S | R | S | R | S | S | 1 (2.3) |
Methods | Locus | No. of alleles in 44 Mycobacterium intracellulare clinical isolates | Allelic diversity (h) | ||||||
---|---|---|---|---|---|---|---|---|---|
0 | 1 | 2 | 3 | 4 | 5 | 6 | |||
VNTR | VNTR1 | — | — | 42 | 2 | — | — | — | 0.089 |
VNTR2 | — | 30 | 8 | 4 | 2 | — | — | 0.503 | |
VNTR3 | 3 | 40 | 1 | — | — | — | — | 0.172 | |
VNTR4 | — | 26 | 5 | 5 | 8 | — | — | 0.606 | |
VNTR5 | 10 | — | 34 | — | — | — | — | 0.359 | |
VNTR6 | 1 | — | 19 | 24 | — | — | — | 0.527 | |
VNTR7 | 1 | 16 | 14 | 12 | 1 | — | — | 0.707 | |
VNTR8 | 22 | — | 22 | — | — | — | — | 0.512 | |
VNTR9 | 4 | 17 | 21 | 2 | — | — | — | 0.627 | |
VNTR10 | — | 31 | 2 | — | 10 | — | — | 0.458 | |
VNTR12 | — | 1 | 31 | 12 | — | — | — | 0.439 | |
VNTR13 | — | — | 27 | 17 | — | — | — | 0.485 | |
VNTR14 | — | 1 | 41 | 2 | — | — | — | 0.132 | |
VNTR15 | — | 29 | 10 | 5 | — | — | — | 0.513 | |
VNTR16 | — | — | 44 | — | — | — | — | 0 | |
MIRU-VNTR | MIN18 | — | — | — | — | 9 | 31 | 4 | 0.464 |
MIN20 | — | — | 11 | 31 | 2 | — | — | 0.449 | |
MIN19 | — | — | 16 | 14 | 14 | — | — | 0.681 | |
MIN22 | — | — | 32 | 3 | 9 | — | — | 0.434 | |
MIN31 | — | — | 35 | 9 | — | — | — | 0.333 | |
MIN33 | — | — | — | 26 | 16 | 2 | — | 0.529 |
PCR = polymerase chain reaction.
AMI = amikacin; AS = antibiotic susceptibility; CIP = ciprofloxacin; CLA = clarithromycin; DOX = doxycycline; LZD = linezolid; MXF = moxifloxacin; R = resistance; RIF = rifampin; S = susceptible; SXT = trimethoprim/sulfamethoxazole.
MIRU-VNTR = mycobacteria interspersed repetitive-unit-variable-number tandem-repeat analysis.